Cancer Of the BReast Asanas Study (COBRA)

ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorUMC Utrecht

About this trial

Rationale: Women with hormone-receptor positive breast cancer are usually prescribed endocrine therapy for a period of 5-10 years. This treatment reduces the risk of recurrence and improves overall survival in these women. Musculoskeletal complaints are a common (\~50%) negative consequence of endocrine treatment, which affects daily functioning and quality of life. These symptoms frequently result in early treatment discontinuation, which is associated with shorter disease-free survival. Musculoskeletal complaints are often pharmacologically treated with limited effect and accompanied by side-effects. Therefore, interventions to counteract musculoskeletal complaints are urgently needed in this population. A potential non-pharmacological option is yoga. In patients with osteoarthritis, there is emerging evidence that yoga is effective to reduce pain and stiffness and improve function. Yoga as treatment for musculoskeletal complaints that are associated with endocrine treatment is rarely investigated and mainly in small studies.

Objective: The objective of the proposed study is to assess the effectiveness of a 4-month yoga program compared to a waiting list control group on musculoskeletal complaints in women with hormone-positive stage I-III breast cancer receiving endocrine treatment who report musculoskeletal complaints.

Study design: The COBRA study is a randomized controlled trial with two study arms: a yoga- and a waiting list control group.

Study population: For this study, 140 women with oestrogen-receptor positive stage I-III breast cancer on endocrine treatment (aromatase inhibitors or Tamoxifen; \>4 months) will be recruited. These women experience musculoskeletal complaints (\>3 months) which started or exacerbated after initiation of endocrine treatment. Furthermore, eligible women did not practice yoga in the last six months and are not planning to start yoga and are not highly physically active (i.e., \>150 minutes per week moderate-vigorous exercise).

Intervention: The intervention consists of two one-hour sessions/week supervised yoga and once a week 30-minute yoga exercises at home. The 4-month yoga program will be an active form of yoga, such as Easy Vinyasa yoga, which is characterized by continuous slow movements linked with breathing. The waiting list control patients will be offered an online yoga program after the 4-month study period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Be diagnosed with oestrogen-receptor positive stage I-III breast cancer,

Use of aromatase inhibitors or Tamoxifen (>4 months and will continue using it for at least six months),

Have finished primary treatment (chemotherapy, radiotherapy, surgery) for at least 12 weeks,

Experience musculoskeletal complaints (>3 months, which are at least mild in severity (i.e., score of ≥ 3 for worst pain item of a modified version of the Brief Pain Inventory [BPI](16, 42))., which started or exacerbated after initiation of endocrine treatment,

Disqualifiers

Too physically active (i.e., >150 minutes/week of self-reported moderate-to-vigorous or leisure and sports activities)

Following (during the last 6 months), or planned to follow yoga classes on a structural base

Following, or planned to follow, a structured psychological intervention during the intervention period, i.e., cognitive behavioral therapy, or unstable on psychotropic medication

Participated in the intervention group of an exercise study during breast cancer treatment

Trial design

Design model

Parallel

Treatments tested in this trial

  • live yoga

    Behavioral

    following live yoga classes twice a week and using yoga video's at home once a week

  • live remote yoga

    Behavioral

    The control group will be offered live remote yoga classes after the intervention period

Treatment groups

140 Participants
are divided into 2 treatment groups
Group A: yoga groupExperimental treatment 1 intervention
Group B: control groupOther 1 intervention

Trial outcomes

Primary outcomes

1

Musculoskeletal complaints

Worst of joint pain and stiffness/joint pain and stiffness severity/joint pain and stiffness interference assessed by the modified version of the BPI. The 14-item questionnaire result in three domain scores: worst pain/stiffness, pain/stiffness severity, and pain/stiffness interference over the past week, on a scale of 0 to 10. All these three domain scores of the BPI will be primary outcomes which will be tested sequentially to preserve an alpha of 0.05. The order of the sequential testing is: 1) worst pain/stiffness, 2) pain/stiffness severity and 3) pain/stiffness interference.

Time frame
Baseline, at 4 and 8 months

Secondary outcomes

1

Lower extremity joint complaints

Using the WOMAC questionnaire

Time frame
Baseline, at 4 and 8 months
2

Upper extremity musculoskeletal complaints

Using the DASH questionnaire

Time frame
Baseline, at 4 and 8 months
3

Menopausal symptoms

Using the FACT-ES questionnaire

Time frame
Baseline, at 4 and 8 months
4

Fatigue

Using the MFI questionnaire

Time frame
Baseline, at 4 and 8 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

UMC Utrecht

Lead sponsor

World Cancer Research Fund International

Collaborator